TABLE 3.

List of ¹⁸F-Amyloid Radiopharmaceuticals and Their Recommended Doses, Uptake Times, and Acquisition Durations

Parameter	Florbetapir^*	Flutemetamol^†	Florbetaben^‡	NAV4694 (80)
Administered activity (MBq)	370 (maximum, 50-μg mass dose)	185 (maximum, 20-μg mass dose)	300 (maximum, 30-μg mass dose)	300
Uptake time (postinjection min)	30–50	90	45–130	50–70
Acquisition duration (min)	10	20	15–20	20

↵* Amyvid (Eli Lilly & Co.) (77).
↵^† Vizamyl (GE Healthcare) (78).
↵^‡ Neuraceq (Piramal Imaging) (79).
Data are per U.S. package inserts. There might be some slight variations in package insert information depending on country of approval.